HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £6.78m
- £7.88m
REG - Hemogenyx Pharma Plc - Opening of First Clinical Site
AnnouncementREG - Hemogenyx Pharma Plc - Ultrafast CAR-T Manufacturing
AnnouncementREG - Official List - Amendment Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 13/12/2024
AnnouncementREG - Hemogenyx Pharma Plc - Admission of New Ordinary Shares and New ISIN
AnnouncementREG - Hemogenyx Pharma Plc - Result of Extraordinary General Meeting
AnnouncementREG - Hemogenyx Pharma Plc - Site Initiation Visit Completed
AnnouncementREG - Hemogenyx Pharma Plc - CBR Macrophage Delivery Update
AnnouncementREG - Hemogenyx Pharma Plc - Total Voting Rights
AnnouncementREG - Hemogenyx Pharma Plc - Notice of Extraordinary General Meeting
AnnouncementREG - Hemogenyx Pharma Plc - IRB Approval for Phase I Clinical Trial
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 15/11/2024
AnnouncementREG - Hemogenyx Pharma Plc - Institutional Investment
AnnouncementREG - Hemogenyx Pharma Plc - Schedule for Phase I Clinical Trial Opening
AnnouncementREG - Hemogenyx Pharma Plc - Strategic Investment from Prevail Partners, LLC
AnnouncementREG - Hemogenyx Pharma Plc - Half-year Report
AnnouncementREG - Hemogenyx Pharma Plc - FLT3 Assay Ready for Phase I Trials at MD Anderson
AnnouncementREG - Hemogenyx Pharma Plc - CDX Development Update
Announcement